Silexion Therapeutics Corp (SLXN) Operating income 2023–2025
Silexion Therapeutics Corp (SLXN) annual operating income history from SEC filings — each fiscal year as reported.
-$11.6MFY2025 · since FY2023: -$4.7M → -$11.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.6M | +7.5% |
| FY2024 | -$12.6M | -168.6% |
| FY2023 | -$4.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SLXN financial trends
SLXN RevenueSLXN Net incomeSLXN Net marginSLXN Gross profitSLXN Gross marginSLXN Operating marginSLXN Operating cash flowSLXN Free cash flowSLXN Capital expendituresSLXN Return on equitySLXN Stock buybacksSLXN Dividends paidSLXN Total assetsSLXN Total liabilitiesSLXN Shareholders’ equitySLXN overview →